Agribusiness, Agriculture, Veterinary Medicine, Cassava, Garri, food security, Agritech and the Red Meat Value Chain.
Showing posts with label Avigan. Show all posts
Showing posts with label Avigan. Show all posts
Wednesday, January 20, 2016
Antiviral favipiravir successfully treats Lassa virus in guinea pigs.
Favipiravir, an investigational antiviral drug currently being tested in West Africa as a treatment for Ebola virus disease, effectively treated Lassa virus infection in guinea pigs, according to a new study. Lassa fever is endemic to West Africa and affects about 300,000 people annually, killing roughly 5,000. In some parts of Sierra Leone and Liberia, it is believed nearly 15 percent of people admitted to hospitals have Lassa fever, according to the Centers for Disease Control and Prevention. No vaccine or licensed treatment exists for Lassa fever, although ribavirin, licensed for hepatitis C treatment, has been used with limited success. In the new study, published Oct. 12, 2015, in Scientific Reports, favipiravir not only effectively treated guinea pigs infected with Lassa virus, it also worked better than ribavirin.
Two days after infecting groups of guinea pigs with a lethal dose of Lassa virus, the scientists treated the rodents daily for two weeks with either ribavirin, low doses of favipiravir, or high doses of favipiravir. They also evaluated the effect of high-dose favipiravir in the rodents that began treatment five, seven or nine days after infection. All of the animals that received high-dose favipiravir were completely protected from lethal infection; animals treated seven or nine days after infection had begun showing signs of disease, but their conditions quickly improved when treatment began. Those animals in the low-dose favipiravir group showed mild to moderate signs of disease, but those symptoms resolved after about one week of treatment. The animals treated with ribavirin appeared normal during the treatment phase but developed severe disease shortly after treatment ended.
Further testing and human clinical trials are needed to determine if favipiravir, also known as T-705 and Avigan, could effectively treat Lassa virus infection in people.
Story source;NIH/National Institute of Allergy and Infectious Diseases.
Subscribe to:
Posts (Atom)
Agribusiness ideas.
Popular Posts
-
Israeli gov't to fund medical cannabis research. The Ministries of Agriculture and Health will provide NIS 8 million in funding for 1...
-
Billionaire Elon Musk is known for his futuristic ideas and his latest suggestion might just save us from being irrelevant as artificial i...
-
Keeping pet trim is good for pet's health and owners' money. Feeding pets indiscriminately with food high in sugar, fat and cert...
-
Farmers, who regularly irrigate bananas, can boot the weight of the fruit by more than 30 per cent. More than 90 per cent of famers in K...
-
The satellite and the chimpanzee,this is how satellite data changed chimpanzee conservation efforts.Chimpanzees are an endangered species ...
-
The regulations require producers who raise cattle, cows, pigs, chickens, turkeys and other animals to obtain a veterinarian’s approval b...
AGRIBUSINESS EDUCATION.
Translate
I-CONNECT -AGRICULTURE
AGRIBUSINESS TIPS.
AGRIBUSINESS.
The Agriculture Daily
veterinarymedicineechbeebolanle-ojuri.blogspot.com Cassava: benefits of garri as a fermented food. Cassava processing involves fermentation which is a plus for gut health. The fermentation process removes the cyanogenic glucosides present in the fres...